Management of acral myxoinflammatory fibroblastic sarcoma.

@article{Tejwani2010ManagementOA,
  title={Management of acral myxoinflammatory fibroblastic sarcoma.},
  author={Ajay Tejwani and Wendy K Kobayashi and Yen-Lin Evelyn Chen and Andrew Eric Rosenberg and Sam Yoon and Kevin A. Raskin and Daniel I. Rosenthal and G. Petur Nielsen and Francis Hornicek and Thomas F Delaney},
  journal={Cancer},
  year={2010},
  volume={116 24},
  pages={5733-9}
}
BACKGROUND Acral myxoinflammatory fibroblastic sarcoma (AMFS) is a rare, low-grade sarcoma that commonly affects the distal extremities. From the published cases, therapy for AMFS to date has been comprised of excision or amputation, with limited use of radiotherapy (RT) or chemotherapy. In this report, the outcome of 17 patients with AMFS treated at the… CONTINUE READING